EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open‐Label Clinical Performance Study

Yang Liu iD, Yulong Chen, Yimei Chen, Xiaohong Jian, Xingguang Zhang, Yufeng Li, Weiwei Zhu, Jing Shen, Yiming Mu iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11927-11935

DOI: 10.1111/dom.71392 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 01.10.2026. Verfasst von Yang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Eighth Medical Center of PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Blood Glucose Self-Monitoring, Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit nennt 13 Literaturangaben. Gefördert von: MicroTech Medical Device (Hangzhou) Co. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate continuous glucose monitoring (CGM) is essential for diabetes management. This study evaluated the accuracy and safety of the LinX CGM system over 15 days in adults with diabetes.

Methods

In this prospective, multicentre, open‐label clinical performance study, 87 adults who wore two LinX sensors were enrolled. Reference glucose was measured using a Biosen analyser. Primary endpoints were the proportions of readings within ±15%/±40% of reference values and mean absolute relative difference (MARD).

Results

Overall MARD was 8.66% (95% CI : 8.27%–9.05%). For glucose concentrations in the range of 3.9–10.0 mmol/L (70–180 mg/ dL ), 87.2% of readings were within ±15%; for concentrations ≥ 10.0 mmol/L (≥ 180 mg/ dL ), 90.2% were within ±15%. Within ±40%, agreement rates were 99.8% and 100.0%, respectively. Sensor survival at 15 days was 96.0%. No serious adverse events occurred.

Conclusion

The LinX CGM system demonstrated good analytical accuracy and favourable short‐term safety over a 15‐day wear period in adults with diabetes. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2200064004

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Glucose Self-MonitoringContinuous Glucose MonitoringDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2AdultAgedFemaleHumansMaleMiddle AgedBlood GlucoseHypoglycemic AgentsProspective StudiesReproducibility of Results

Stichwörter der Autor:innen

accuracyclinical trialcontinuous glucose monitoringdiabetes mellitussafety

Substanzen

Blood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Endocrinology, The Eighth Medical Center of PLA General Hospital, Beijing, China.
  • Department of Endocrinology, The First Medical Center of PLA General Hospital, Beijing, China.
  • Department of Endocrinology, The Seventh Medical Center of PLA General Hospital, Beijing, China.
  • Department of Endocrinology, Beijing Pinggu Hospital, Beijing, China.
  • Microtech Medical Device (Hangzhou) Co. Ltd., Hangzhou, Zhejiang, China.

ORCID-Profile: Yang Liu, Yiming Mu

Förderung

  • MicroTech Medical Device (Hangzhou) Co. Ltd.

Zitieren

APA

Liu, Y., Chen, Y., Chen, Y., Jian, X., Zhang, X., Li, Y., Zhu, W., Shen, J., & Mu, Y. (2026). Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open‐Label Clinical Performance Study. Diabetes, Obesity and Metabolism, 28(12), 11927-11935. https://doi.org/10.1111/dom.71392

Vancouver

Liu Y, Chen Y, Chen Y, Jian X, Zhang X, Li Y, et al. Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open‐Label Clinical Performance Study. Diabetes, Obesity and Metabolism. 2026;28(12):11927-11935. doi:10.1111/dom.71392

BibTeX
@article{Liu2026,
  author = {Liu, Yang and Chen, Yulong and Chen, Yimei and Jian, Xiaohong and Zhang, Xingguang and Li, Yufeng and Zhu, Weiwei and Shen, Jing and Mu, Yiming},
  title = {Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open‐Label Clinical Performance Study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11927--11935},
  doi = {10.1111/dom.71392}
}
Kostenlos starten →